SCHEMBL8092832

SCHEMBL8092832

C[CH]C(c1ccccc1)N(CCCc1ccccc1)Cc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 5/20 0.57
SLC6A2 P23975 2/20 0.47
SLC6A4 P31645 2/20 0.47
SLC6A3 Q01959 2/20 0.47
CHRM2 P08172 1/20 0.47
HTR1A P08908 1/20 0.47
ADRA2A P08913 1/20 0.47
CHRM1 P11229 1/20 0.47
DRD1 P21728 1/20 0.47
ADRA1A P35348 1/20 0.47
OPRM1 P35372 1/20 0.47
DRD3 P35462 1/20 0.47
KCNH2 Q12809 1/20 0.47
AOC3 Q16853 1/20 0.44
BCHE P06276 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8092827 0.73 SIGMAR1 (1.00) SIGMAR1SLC6A2SLC6A4SLC6A3CHRM2
SCHEMBL27628280 0.71 SIGMAR1 (0.40) SIGMAR1SLC6A2SLC6A4SLC6A3CHRM2
SCHEMBL8828024 0.70 CHRM2 (0.67) SIGMAR1SLC6A2SLC6A4SLC6A3CHRM2
SCHEMBL18765875 0.68 TSHR (0.39) SIGMAR1SLC6A2SLC6A4SLC6A3ADRA1A
SCHEMBL18765877 0.68 TSHR (0.39) SIGMAR1SLC6A2SLC6A4SLC6A3ADRA1A
SCHEMBL12126329 0.68 KCNH2 (0.81) SLC6A2SLC6A4SLC6A3CHRM2HTR1A
SCHEMBL10817335 0.68 KCNH2 (0.75) SIGMAR1SLC6A2SLC6A4SLC6A3CHRM2
SCHEMBL8091032 0.68 SIGMAR1 (0.50) SIGMAR1SLC6A2SLC6A4SLC6A3CHRM2
SCHEMBL2949711 0.68 SIGMAR1 (0.85) SIGMAR1SLC6A2SLC6A4SLC6A3CHRM2
Hydrochloric Acid SCHEMBL28041497 0.67 KCNH2 (0.79) SLC6A2SLC6A4SLC6A3CHRM2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6057371-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION VIRGINIA COMMONWEALTH UNIVERSITY (US) 2000-05-02 US claimed
EP-0591426-A1 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1994-04-13 EP claimed
WO-1993000313-A2 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1993-01-07 WO claimed
US-6057371-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION VIRGINIA COMMONWEALTH UNIVERSITY (US) 2000-05-02 US disclosed
EP-0591426-A1 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1994-04-13 EP disclosed
WO-1993000313-A2 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1993-01-07 WO disclosed